Join to View Full Profile
1055 N 500 WSte 202Provo, UT 84604
Phone+1 801-374-2367
Fax+1 801-374-2367
Dr. Esplin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2014 - 2017- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2011 - 2014
University of Oklahoma College of MedicineClass of 2011
Certifications & Licensure
UT State Medical License 2017 - 2026
MN State Medical License 2012 - 2018
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 4 citationsA Phase II Study of Pazopanib in Patients with Malignant Pleural Mesothelioma: NCCTG N0623 (Alliance).Kaushal Parikh, Sumithra J. Mandrekar, Katie Allen-Ziegler, Brandt L. Esplin, Angelina D. Tan
The Oncologist. 2020-06-01 - 26 citationsPembrolizumab induced severe sclerodermoid reactionNiraj Shenoy, B. Esplin, Naiara S. Barbosa, Carilyn N. Wieland, Uma Thanarajasingam
Annals of Oncology. 2017-02-01 - 79 citationsThe use of pembrolizumab for the treatment of metastatic uveal melanoma.Lisa A. Kottschade, Robert R. McWilliams, Svetomir N. Markovic, Matthew S. Block, Jose Villasboas Bisneto
Melanoma Research. 2016-06-01
Grant Support
- Chronic Toll-Like Receptor Ligation And Hematopoietic Stem Cell AgingNational Institute On Aging2008–2010
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
